# Hypofractionated Radiotherapy After Complete Resection for Stage II/III Thymic Epithelial Tumors

> **NCT07691619** · PHASE2 · RECRUITING · sponsor: **Tianjin Medical University Cancer Institute and Hospital** · enrollment: 49 (estimated)

## Conditions studied

- Thymic Epithelial Tumor

## Interventions

- **RADIATION:** Postoperative hypo-fractionated radiotherapy

## Key facts

- **NCT ID:** NCT07691619
- **Lead sponsor:** Tianjin Medical University Cancer Institute and Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-14
- **Primary completion:** 2027-06-30
- **Final completion:** 2029-06-30
- **Target enrollment:** 49 (ESTIMATED)
- **Last updated:** 2026-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07691619

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07691619, "Hypofractionated Radiotherapy After Complete Resection for Stage II/III Thymic Epithelial Tumors". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07691619. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*